Vice President Clinical Development - Remote

Overview

The Vice President Clinical Development will lead the clinical strategy for pivotal Phase 3 programs in Frontotemporal Dementia, working cross-functionally to drive regulatory engagement and execution of clinical leadership.

In Short

• Lead clinician for Phase 3 program in Frontotemporal Dementia.
• Own post-readout clinical strategy and execution.
• Lead regulatory engagement with the US FDA.
• Work cross-functionally with Clinical Operations, Regulatory Affairs, Biometrics, and Commercial teams.
• Drive clinical leadership toward potential filing and launch.
• Integrate AI technologies to improve decision-making.
• Provide clinical insights for program decisions.
• Ensure patient safety and regulatory compliance.
• Focus on late-stage study execution and potential BLA filing.
• Collaborate with cross-functional colleagues effectively.

Requirements

• MD, MD/PhD with 10+ years of clinical drug development experience.
• Proven track record in rare diseases or CNS/neurodegenerative disease.
• Successful history of leading FDA interactions and drug launches.
• Ability to work independently in fast-paced environments.
• Experience influencing cross-functional colleagues.
• Active user of large language models (LLMs).
• Strong interest in AI applications in clinical development.

Benefits

• Opportunity to impact the future of medicine.
• Collaborative team environment.
• Work on innovative therapies for neurodegeneration.
• Access to leading healthcare investors and partners.
• Support from experienced scientists and clinicians.